Theratechnologies shares hit by FDA findings
Theratechnologies shares hit by FDA findings
Theratechnologies Inc. lost half its market value Tuesday after a review by the U.S. Food and Drug Administration said the Canadian biopharmaceutical company’s key drug reduced abdominal fat in patients with the Human Immunodeficiency Virus, but might increase the risk of diabetes
Read more on National Post
More Meth Drug Addiction Info:
- FDA and NIH Launch Electronic Safety Reporting Portal « ResourceShelf
- 21st Century Essential Guide to Biotechnology and the Center for …
- Improving Transparency at the Food and Drug Administration: We …
- Suven's neurodegenerative leads get Canadian & Eurasian patents …
- Health Freedom Alliance » Top 50 Pharmaceutical Companies
- News » INDIA'S SPACE ENTRY OPENS NEW HORIZONS IN EDUCATION SECTOR
- FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial …
- Is it Time for the FDA to Chime in on Drug Company Tweets? | Xconomy
- Blood Test For Hiv Free STD Testing
- Perrigo Gets FDA Warning Letter Over Tainted Ibuprofen | NEWS Gate